No cancer risk reprt: Bimatoprost (Lumigan™, Latisse™) is an intraocular pressure reducing drug when instilled onto the eye surface. Side effects include lash growth enhancement and potential iris color changes,periocular pigmentary changes, periocular fat changes, inflammation of eyelids, uveitis, macular edema, burning, and blurring of vision. Cancer risk has not been reported to my knowledge.
Answered 10/21/2017
1.1k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
4 doctors weighed in across 3 answers
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question